The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain

Alternate title: 
J2 - Palliat Med
Secondary title: 
T2 - Palliative medicine
Short title: 
The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain
Authors: 
Lasheen, Wael
Walsh, Declan
Mahmoud, Fade
Sarhill, Nabeel
Rivera, Nilo
Davis, Mellar
Lagman, Ruth
Legrand, Susan
Volume: 
24
Start page: 
9-16
Annotations: 
Type D, Priority 5
Date: 
Jan
Year: 
2010
Accession number: 
19910396
Database: 
MEDLINE Cohort
Number: 
M1 - 1
Serial: 
1477-030X
ID: 
12863
DOI: 
http://dx.doi.org/10.1177/0269216309346595
Notes: 
N1 - Lasheen W Walsh D Mahmoud F Sarhill N Rivera N Davis M Lagman R Legrand S
Key words: 
Administration, Oral
Adult
Aged
Aged, 80 and over
*Analgesics, Opioid/ad [Administration & Dosage]
Analgesics, Opioid/ae [Adverse Effects]
*Analgesics, Opioid/pk [Pharmacokinetics]
Chronic Disease
Dose-Response Relationship, Drug
Female
Humans
Injections, Intravenous
Male
Middle Aged
*Morphine/ad [Administration & Dosage]
Morphine/ae [Adverse Effects]
*Morphine/pk [Pharmacokinetics]
*Neoplasms/co [Complications]
*Neoplasms/me [Metabolism]
*Pain/dt [Drug Therapy]
Pain/et [Etiology]
Pain/me [Metabolism]
Pain Measurement/de [Drug Effects]
Palliative Care/mt [Methods]
Prospective Studies
Single-Blind Method
Therapeutic Equivalency
Treatment Outcome
0 (Analgesics, Opioid)
76I7G6D29C (Morphine)
Types of evidence: 
Type D
Priorities of Care: 
Priority 5: Plan and do